Back to Search Start Over

Theta-frequency medial septal nucleus deep brain stimulation increases neurovascular activity in MK-801-treated mice.

Authors :
Crown LM
Agyeman KA
Choi W
Zepeda N
Iseri E
Pahlavan P
Siegel SJ
Liu C
Christopoulos V
Lee DJ
Source :
Frontiers in neuroscience [Front Neurosci] 2024 Mar 15; Vol. 18, pp. 1372315. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Publication Year :
2024

Abstract

Introduction: Deep brain stimulation (DBS) has shown remarkable success treating neurological and psychiatric disorders including Parkinson's disease, essential tremor, dystonia, epilepsy, and obsessive-compulsive disorder. DBS is now being explored to improve cognitive and functional outcomes in other psychiatric conditions, such as those characterized by reduced N-methyl-D-aspartate (NMDA) function (i.e., schizophrenia). While DBS for movement disorders generally involves high-frequency (>100 Hz) stimulation, there is evidence that low-frequency stimulation may have beneficial and persisting effects when applied to cognitive brain networks.<br />Methods: In this study, we utilize a novel technology, functional ultrasound imaging (fUSI), to characterize the cerebrovascular impact of medial septal nucleus (MSN) DBS under conditions of NMDA antagonism (pharmacologically using Dizocilpine [MK-801]) in anesthetized male mice.<br />Results: Imaging from a sagittal plane across a variety of brain regions within and outside of the septohippocampal circuit, we find that MSN theta-frequency (7.7 Hz) DBS increases hippocampal cerebral blood volume (CBV) during and after stimulation. This effect was not present using standard high-frequency stimulation parameters [i.e., gamma (100 Hz)].<br />Discussion: These results indicate the MSN DBS increases circuit-specific hippocampal neurovascular activity in a frequency-dependent manner and does so in a way that continues beyond the period of electrical stimulation.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.<br /> (Copyright © 2024 Crown, Agyeman, Choi, Zepeda, Iseri, Pahlavan, Siegel, Liu, Christopoulos and Lee.)

Details

Language :
English
ISSN :
1662-4548
Volume :
18
Database :
MEDLINE
Journal :
Frontiers in neuroscience
Publication Type :
Academic Journal
Accession number :
38560047
Full Text :
https://doi.org/10.3389/fnins.2024.1372315